St. Jude CEO: Childhood Cancer Cures Within Reach

When St. Jude Children's Research Hospital opened in 1962, only 20% of kids with cancer survived. Today, more than 80% do, and the hospital's incoming CEO says we're standing at the edge of something even more remarkable.

Dr. Charles Roberts will become St. Jude's new leader on January 1st, taking over after a global search that looked for someone who could push childhood cancer treatment into uncharted territory. He told the Associated Press that technological advances are converging right now to create a "once-in-a-lifetime opportunity" to achieve breakthroughs that seemed impossible just years ago.

Roberts has spent the past decade building St. Jude's Comprehensive Cancer Center into what the National Cancer Institute calls a "national treasure." His research has helped confirm how certain genes can suppress tumor growth, and he plans to keep working in the lab even as CEO.

The new treatments emerging from this technological convergence do something incredible: they kill cancer more effectively while causing less harm to young patients. It's the kind of double win that researchers dream about.

St. Jude continues to treat every patient for free, never charging families a single dollar. The hospital raises an average of $2.3 billion annually through donations, making its fundraising arm the second-largest in America behind only United Way.

Why This Inspires

Childhood cancers get far less research funding than adult cancers because pharmaceutical companies see smaller financial returns. But St. Jude has refused to let market forces decide which kids get a chance at life.

Instead, millions of donors have stepped in to fill that gap, proving that when institutions focus on mission over profit, extraordinary things become possible. Roberts said those donations help St. Jude push treatments forward that might never happen otherwise.

The hospital is also expanding globally, working to make these breakthrough treatments available to more children worldwide. Marlo Thomas, daughter of St. Jude founder Danny Thomas, said her father's dream that "no child should die in the dawn of life" has never been closer to reality.

Roberts brings together three rare qualities: the precision of a top researcher, the compassion of a physician who treats patients, and the vision of a leader who can steer a massive institution toward ambitious goals. His predecessor recruited him in 2015 specifically because he saw that combination.

The journey from 20% survival to 80% took more than six decades of painstaking work. If Roberts is right about what's coming next, the leap to making all childhood cancers treatable might happen much faster than anyone expected.